Nureca Ltd

Nureca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nureca Ltd

₹ 290 4.98%
28 Nov - close price
nureca.com BSE: 543264 NSE: NURECA
About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]

Key Points

Business Overview:[1][2]
NL is a digitally first, consumer healthcare company with presence in categories such
as home diagnostics, wellness devices, and personal fitness equipment under brands like
Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26

Website BSE NSE - BE
  • Market Cap ₹ 290 Cr.
  • Current Price ₹ 290
  • High / Low ₹ 448 / 198
  • Stock P/E 70.5
  • Book Value ₹ 199
  • Dividend Yield 0.00 %
  • ROCE -0.90 %
  • ROE -1.12 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • The company has delivered a poor sales growth of 1.98% over past five years.
  • Company has a low return on equity of -3.23% over last 3 years.
  • Earnings include an other income of Rs.8.36 Cr.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -5.03%
  • Working capital days have increased from 255 days to 434 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
36.78 27.79 21.23 21.23 31.35 22.37 16.97 20.27 31.19 26.46 31.74 34.18 37.74
41.69 28.71 24.69 24.13 29.97 26.62 21.40 22.63 33.54 30.47 30.54 34.74 34.47
Operating Profit -4.91 -0.92 -3.46 -2.90 1.38 -4.25 -4.43 -2.36 -2.35 -4.01 1.20 -0.56 3.27
OPM % -13.35% -3.31% -16.30% -13.66% 4.40% -19.00% -26.10% -11.64% -7.53% -15.15% 3.78% -1.64% 8.66%
1.89 1.90 2.15 2.67 3.20 5.90 -1.26 5.79 3.17 1.48 1.99 2.57 2.32
Interest 0.10 0.11 0.10 0.12 0.08 0.11 0.18 0.15 0.27 0.18 0.62 0.25 0.46
Depreciation 0.62 0.60 0.56 0.58 0.59 0.59 0.60 0.66 0.62 0.54 0.52 0.53 0.54
Profit before tax -3.74 0.27 -1.97 -0.93 3.91 0.95 -6.47 2.62 -0.07 -3.25 2.05 1.23 4.59
Tax % -22.73% -11.11% -22.34% -23.66% 25.83% 82.11% -35.86% 36.64% 585.71% -13.85% -20.00% 34.15% 21.13%
-2.89 0.30 -1.53 -0.71 2.89 0.17 -4.15 1.66 -0.48 -2.80 2.47 0.81 3.63
EPS in Rs -2.89 0.30 -1.53 -0.71 2.89 0.17 -4.15 1.66 -0.48 -2.80 2.47 0.81 3.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
62 99 213 256 111 92 110 130
53 90 152 200 126 102 117 130
Operating Profit 9 10 62 56 -15 -10 -8 -0
OPM % 15% 10% 29% 22% -13% -11% -7% -0%
0 0 3 8 7 11 12 8
Interest 0 1 2 1 0 0 1 2
Depreciation 0 0 0 1 2 2 2 2
Profit before tax 9 9 62 61 -11 -3 1 5
Tax % 30% 26% 26% 26% -23% -30% 37%
6 6 46 45 -8 -2 1 4
EPS in Rs 6,230.00 6,400.00 46.37 44.96 -8.25 -1.79 0.85 4.11
Dividend Payout % 0% 0% 4% 7% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 2%
3 Years: -25%
TTM: 43%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 247%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -17%
1 Year: 2%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: -3%
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.01 0.01 10 10 10 10 10 10
Reserves 8 15 153 193 185 183 184 189
0 10 4 4 3 3 5 5
15 9 19 12 8 10 11 21
Total Liabilities 24 34 186 219 207 205 210 225
1 1 4 10 9 7 9 14
CWIP 0 0 0 0 0 0 0 0
Investments 0 0 0 33 59 94 1 8
23 33 182 175 139 104 200 203
Total Assets 24 34 186 219 207 205 210 225

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 -8 35 1 10 -3 -19
-0 -0 -110 -3 -16 18 8
-0 8 92 -7 -2 -1 -0
Net Cash Flow 0 -0 17 -9 -8 14 -11

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 52 47 0 4 14 6 11
Inventory Days 123 93 135 174 167 186 214
Days Payable 89 33 32 13 24 31 35
Cash Conversion Cycle 87 107 103 165 157 161 190
Working Capital Days 45 85 61 109 156 176 434
ROCE % 57% 67% 33% -6% -4% -1%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
62.98% 62.98% 62.98% 63.24% 63.24% 63.24% 63.24% 63.78% 64.06% 64.30% 64.33% 64.97%
0.10% 0.10% 0.10% 0.10% 0.07% 0.07% 0.07% 0.69% 0.36% 1.07% 0.07% 0.07%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.04% 0.04% 0.04%
36.92% 36.91% 36.92% 36.67% 36.69% 36.69% 36.69% 35.53% 35.54% 34.59% 35.56% 34.92%
No. of Shareholders 62,00758,56055,56952,25549,60045,99643,81341,98641,31439,30438,07537,468

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Oct 2025
    Transcript
    Notes
    PPT
  • Jul 2025
    Transcript
    Notes
    PPT
  • May 2025
    Transcript
    Notes
    PPT
  • Jan 2025
    Transcript
    Notes
    PPT
  • Oct 2024
    Transcript
    Notes
    PPT
  • Aug 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT